Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1999;94:279-283
© 1999 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FUJINO, T.
Right arrow Articles by NAGATA, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FUJINO, T.
Right arrow Articles by NAGATA, Y.

ORIGINAL RESEARCH

Apoptosis in Placentas From Human T-Lymphotropic Virus Type I–Seropositive Pregnant Women: A Possible Defense Mechanism Against Transmission From Mother to Fetus

TOSHINORI FUJINO, MD, ICHIRO IWAMOTO, MD, HIROFUMI OTSUKA, MD, TOSHIRO IKEDA, MD, SHUNJI TAKESAKO, MD and YUKIHIRO NAGATA, MD

From the School of Health Sciences and the Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.

Address reprint requests to: Toshinori Fujino, MD School of Health Sciences Kagoshima University 8-35-1 Sakuragaoka Kagoshima, 890-8506 Japan E-mail: toshinet{at}health.nop.kagoshima-u-ac-jp

Objective: The mechanism by which the placenta serves as the barrier against mother-to-fetus transmission of microorganisms remains to be elucidated. Programmed cell death, apoptosis, is considered a cellular defense mechanism against infection. The hypothesis of this study is that apoptosis of human T-lymphotropic virus type I (HTLV-I)–infected placental villous cells is involved in the defense mechanism against mother-to-fetus transmission of HTLV-I.

Methods: Apoptosis was compared in term placentas from eight HTLV-I–seropositive pregnant women and eight HTLV-I–seronegative pregnant women by the terminal deoxynucleotidyl transferase-mediated deoxyuridine nick end-labeling method. In addition, an in vitro cocultivation with an HTLV-I–infected lymphocyte cell line (MT-2 cells) was performed to examine whether placental villous cells were infected with HTLV-I and apoptosis was induced.

Results: The incidence of apoptosis-positive cells (nuclei) in placentas from the HTLV-I–seropositive pregnant women was higher than in the HTLV-I–seronegative pregnant women (P < .02). Cocultivation with MT-2 cells showed that trophoblast cells were able to be infected with HTLV-I and that apoptosis was induced in the placental villous cells.

Conclusion: HTLV-I infection induces apoptosis in the placenta. We speculate that apoptosis may be involved in the defense mechanism of the placenta against mother-to-fetus transmission of HTLV-I.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Obstetricians and Gynecologists.